These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31389139)

  • 1. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.
    Schifani C; Pruessner J; Tseng HH; Rao N; Tagore A; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Addict Biol; 2020 Jul; 25(4):e12812. PubMed ID: 31389139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [
    Tagore A; Schifani C; Rao N; Tseng HH; Zakzanis KK; Rusjan PM; Houle S; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1023-1032. PubMed ID: 31351843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use.
    Mizrahi R; Kenk M; Suridjan I; Boileau I; George TP; McKenzie K; Wilson AA; Houle S; Rusjan P
    Neuropsychopharmacology; 2014 May; 39(6):1479-89. PubMed ID: 24385130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.
    Mizrahi R; Suridjan I; Kenk M; George TP; Wilson A; Houle S; Rusjan P
    Neuropsychopharmacology; 2013 Mar; 38(4):673-82. PubMed ID: 23212454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.
    Rao N; Northoff G; Tagore A; Rusjan P; Kenk M; Wilson A; Houle S; Strafella A; Remington G; Mizrahi R
    Schizophr Bull; 2019 Apr; 45(3):670-679. PubMed ID: 29878197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.
    Hernaus D; Collip D; Kasanova Z; Winz O; Heinzel A; van Amelsvoort T; Shali SM; Booij J; Rong Y; Piel M; Pruessner J; Mottaghy FM; Myin-Germeys I
    Transl Psychiatry; 2015 Apr; 5(4):e547. PubMed ID: 25871972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased stress-induced dopamine release in psychosis.
    Mizrahi R; Addington J; Rusjan PM; Suridjan I; Ng A; Boileau I; Pruessner JC; Remington G; Houle S; Wilson AA
    Biol Psychiatry; 2012 Mar; 71(6):561-7. PubMed ID: 22133268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [¹⁸F]fallypride.
    Lataster J; Collip D; Ceccarini J; Haas D; Booij L; van Os J; Pruessner J; Van Laere K; Myin-Germeys I
    Neuroimage; 2011 Oct; 58(4):1081-9. PubMed ID: 21801840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [
    Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.
    Kuepper R; Ceccarini J; Lataster J; van Os J; van Kroonenburgh M; van Gerven JM; Marcelis M; Van Laere K; Henquet C
    PLoS One; 2013; 8(7):e70378. PubMed ID: 23936196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
    Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced dopamine release in human medial prefrontal cortex--18F-fallypride/PET study in healthy volunteers.
    Nagano-Saito A; Dagher A; Booij L; Gravel P; Welfeld K; Casey KF; Leyton M; Benkelfat C
    Synapse; 2013 Dec; 67(12):821-30. PubMed ID: 23939822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis.
    Kasanova Z; Ceccarini J; Frank MJ; van Amelsvoort T; Booij J; Heinzel A; Mottaghy FM; Myin-Germeys I
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1314-1324. PubMed ID: 30482598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.
    Soliman A; O'Driscoll GA; Pruessner J; Holahan AL; Boileau I; Gagnon D; Dagher A
    Neuropsychopharmacology; 2008 Jul; 33(8):2033-41. PubMed ID: 17957215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.
    Zakiniaeiz Y; Hillmer AT; Matuskey D; Nabulsi N; Ropchan J; Mazure CM; Picciotto MR; Huang Y; McKee SA; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2019 Dec; 44(13):2205-2211. PubMed ID: 31269510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
    Tseng HH; Watts JJ; Kiang M; Suridjan I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Bull; 2018 Apr; 44(3):542-551. PubMed ID: 29036383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.